logo image
  • Home
  • PIPELINE
  • About
  • Contacts
  • NEWS

October 2026: Expanding Our Portfolio of Intellectual Property & Innovation Track Record Hager Biosciences continues to expand its portfolio of granted patents, reflecting a productive, strategically focused, and capital-efficient approach to therapeutic drug discovery and development. These achievements underscore our commitment to generating innovative, differentiated molecular entities with the potential to address significant unmet medical needs. Our strategy is designed to create long-term value by translating scientific innovation into protected intellectual property assets that support future development, partnering, and licensing opportunities. Each granted patent represents an important milestone in advancing our research programs and strengthening the foundation for future growth. As we pursue the discovery of the next generation of novel therapeutics, our growing patent portfolio reflects both our commitment to scientific innovation and our focus on delivering meaningful value from our R&D investments. In our quest to contribute to the next generation of novel medications to address pressing unmet medical needs, thrilled to see recently several patents granted from Hager discovery research:

US-12,760,030-B2 (2026-10-13)

US-12,528,819-B2 (2026-01-20)

US-12,291,535-B2 (2025-05-06)

US-12,275,744-B2 (2025-04-15)

US-12,187,737-B2 (2025-01-07)

US-12,187,738-B2 (2025-01-07)

US-12,024,525-B2 (2024-07-02)


2026 Published & Pending Patent Applications:

Pyrazole And Imidazole Derivatives as Dual Orexin and Kappa-Opioid Receptors Modulators Composition, Methods for Treating Neurological and Neuropsychiatric Disorders; US-20260070922-A1 (2026-03-12).

Substituted Pyrazoles and Imidazoles as Orexin Receptor Antagonists Composition, Methods for Treating Neurological and Neuropsychiatric Disorders; US-20260256807-A1 (2026-09-03).


pipeline
About
Contacts
Contact info
info@hagerbio.com
610-849-5075
Address
116 Research Drive, Suite 265, PA 18015, USA
© Copyright 2026 Hager Biosciences, LLC. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept, you consent to our use of cookies. Cookies and Privacy Policy.

Your Cookie Settings

We use cookies to enable essential functionality on our website and analyze website traffic. For more information, read our Cookies and Privacy Policy below.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites.

Analytics

These cookies collect information that is used in aggregate and in an anonymized form to help us understand how our website is being used and how effectively our site is performing.